Postural Stability and Ankle Mobility in Haglund Syndrome

June 13, 2023 updated by: Nassif Magdy Mousa, Cairo University

Evaluation of Postural Stability and Ankle Mobility in Haglund Syndrome

The purpose of the study is to find out the impact of Haglund syndrome on ankle plantarflexion and dorsiflexion ROM, dynamic postural stability and fall risk.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This study will be delimited to:

  • Total sample size is fifty participants, twenty five patient of symptomatic Haglund syndrome of both gender and twenty five healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs.
  • Biodex balance system will be used to determine postural stability.
  • Ankle plantarflexion and dorsiflexion range of motion will be measured using an Electrogoniometer.
  • Age of the patients 25-56
  • BMI of (18.5 to 24.9)

Participants:

Fifty volunteers from both genders will participate in the study. They will be assigned from outpatient clinic of Faculty of Physical Therapy, Deraya University. They will be interviewed and divided to twenty five patient of Haglund syndrome as (patient group) after being diagnosed and referred by orthopedic surgeon and twenty five Healthy volunteers as (control group) based on the following inclusion and exclusion criteria:

Study Type

Observational

Enrollment (Estimated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: enas F youssif, prof
  • Phone Number: cairo 01127867507

Study Locations

      • Minya, Egypt, 05673
        • Recruiting
        • Deraya University
        • Contact:
        • Contact:
          • mohamed A abdelmegeed, PHD
          • Phone Number: 01223631604

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

patients with Haglund syndrome

Description

Inclusion Criteria:

  • For patient group:

    • Patient referred from orthopedic surgeon with diagnoses as Haglund syndrome according to the following signs and symptoms
    • Calcaneal prominence diagnosed on lateral weight bearing radiograph with bony prominence superior to parallel pitch lines or posterior calcaneal angle greater than 75 degrees
    • Pain medially at insertion of tendo-achilles
    • Palpation of hard, bony prominence
    • Pain upon rising out of bed
    • Both unilateral and bilateral cases, and in consideration of dealing with bilateral cases the tested limb will be the most painful limb.
    • Age of 25-56 years
    • Both males and females.
    • BMI of (18.5 to 24.9)

For control group:

Healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs and will be included in the control group in this study .

Exclusion Criteria:

  • Musculoskeletal disorders except Haglund syndrome
  • cognitive disorder, visual impairment that affected their daily living and any further medical condition that would prohibit them from participating safely in the chosen balance measures
  • sensory loss at foot or ankle and with a systemic inflammatory disease, such as diabetes mellitus, peripheral neuropathy, rheumatoid arthritis and ankylosing spondylitis, who had undergone corticosteroid injections or physical therapy in the last three months
  • Patients with vestibular or neurological disorders
  • Any other cause of posterior heel pain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patient group
to twenty five patient of Haglund syndrome as (patient group) after being diagnosed and referred by orthopedic surgeon and twenty
assessment of postural stability and ankle range of motion
control group
twenty five Healthy volunteers as (control group) based on the following inclusion and exclusion criteria
assessment of postural stability and ankle range of motion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postural stability test report
Time Frame: 1 day
a measurement of the antero-posterior, medio-lateral and overall stability and range of motion
1 day
ankle range of motion test
Time Frame: 1 day
measuring of ankle planter and dorsiflexion range of motion with digital goniometer
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: enas F youssif, prof, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2023

Primary Completion (Estimated)

July 30, 2023

Study Completion (Estimated)

September 1, 2023

Study Registration Dates

First Submitted

June 6, 2023

First Submitted That Met QC Criteria

June 13, 2023

First Posted (Actual)

June 15, 2023

Study Record Updates

Last Update Posted (Actual)

June 15, 2023

Last Update Submitted That Met QC Criteria

June 13, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/ 012/004497

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

publication in peer-reviewed journals

IPD Sharing Time Frame

year

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Haglund Deformity

Clinical Trials on balance and ROM assessment

Subscribe